Description
Esbriet (Pirfenidone) is a medication used to treat idiopathic pulmonary fibrosis (IPF). It belongs to a class of drugs called pyridones and works by reducing the production of certain substances in the body that contribute to lung scarring. Patients looking to buy Esbriet medication should be aware that it is available by prescription only, and the Esbriet cost may vary depending on the pharmacy and insurance coverage.
Fact Table |
Formula |
C12H11NO |
License |
US DailyMed, EU EMA |
Bioavailability |
46% |
Legal status |
Rx-only |
Chemical Name |
Pirfenidone |
Elimination half-life |
2.4 hours |
Dosage (Strength) |
200mg, 267mg, 600mg, 801mg |
Pregnancy |
Consult Doctor |
Brands |
Esbriet |
Protein binding |
50–58% |
PubChem CID |
40632 |
MedlinePlus |
a615008 |
ChEBI |
32016 |
ATC code |
L04AX05 |
DrugBank |
Not Available |
KEGG |
D01583 |
Routes of administration |
Oral |
Directions
The standard dosage of Esbriet is three capsules (or a total of 801 mg) three times daily. Each dose should be taken with food at consistent times each day, such as in the morning, afternoon, and evening. Maintaining this schedule can help maintain stable levels of the medication in the body and support its effectiveness. Always follow your doctor's instructions when using Esbriet to manage idiopathic pulmonary fibrosis.
Ingredients
The primary ingredient in Esbriet ispirfenidone.
Contraindications
There are no labeled contraindications on the drug label. However, the drug may need to be avoided in individuals with severe liver disease or end-stage kidney stage.
Cautions
- Before starting Esbriet, it's important to inform your doctor about:
- Any medications you take, especially those that may interact with Esbriet, such as certain antibiotics
- Existing medical conditions, particularly liver problems, as Esbriet can affect liver function
- If you are pregnant, breastfeeding, or planning to do either, as this drug may not be appropriate
- The use of Esbriet may cause an increase in liver enzymes. The dosage may need to be reduced or discontinued in some cases of liver enzyme changes.
- Esbriet may cause increased sensitivity to sunlight, requiring protective clothing and sunscreen usage.
- Esbriet may cause gastrointestinal problems, such as nausea, vomiting, or diarrhea.
- Regular monitoring for negative side effects may be needed in order to evaluate whether dosage adjustments or discontinuation of Esbriate is required.
- People who smoke may experience reduced exposure to Esbriet, possibly affecting the drug's effectiveness.
Side Effects
Like all medications, Esbriet may have some side effects. The most common side effects include nausea, vomiting, diarrhea, indigestion, heartburn, and stomach pain. Other common side effects are dizziness, fatigue, gastroesophageal reflux disease, skin rash, upper abdominal pain, weight loss, and decreased appetite.
There are potentially severe side effects associated with Esbriet, such as severe skin reactions like skin blisters, rash, sores in the mouth, or other severe skin symptoms. Report any severe side effects to a healthcare professional immediately.
References:
- Esbriet Prescribing Information. Brisbane, CA: InterMune, Inc.; 2023.
- Esbriet Safety Information. Genentech. Accessed August 9, 2023.
About Dr. Gerardo Sison (Page Author)
Dr. Sison graduated with honors from the University of Florida. He began his career in pharmacy counseling patients in a community setting and later served in hospitals and clinics. He has also worked in medication therapy management services. Read More....
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.
Product Code : 13792